
Human Hepatocytes Case Studies Brochure
Drug discovery and development increasingly incorporate New Approach Methodologies (NAMs) and human-relevant in vitro models to better predict human biological responses and reduce reliance on

Drug discovery and development increasingly incorporate New Approach Methodologies (NAMs) and human-relevant in vitro models to better predict human biological responses and reduce reliance on

Have your research featured through Discovery’s Hepatic Science Spotlight Package. Purchase Gentest® Human Hepatocytes and receive a complimentary contentpackage valued at $10,000, designed to showcase

Supplier instability shouldn’t stall your research. If delayed shipments, poor communication, or inconsistent quality are slowing you down, Discovery Life Sciences is ready to step

Discovery Life Sciences (Discovery) has integrated theBiocartis Idylla® platform into its specialty laboratories inNewtown, Pennsylvania and Kassel, Germany, enabling rapid,harmonized PCR testing for global clinical

Better preclinical models improve clinical success. Human primary cell–based drug efficacy and hematotoxicity assays are new approach methodologies (NAMs) that can deliver clinically predictive insights

Understanding how a drug candidate is metabolized, transported, and cleared is an essential part of the drug development process. Discovery Life Sciences’ (Discovery’s) Gentest® ADME

Discovery Life Sciences provides precise and accurate measurement of analytes in biological matrices to support safe, informed research decisions. We offer both qualitative and quantitative

Discovery Life Sciences (Discovery) accelerates the path from biospecimen to breakthrough — delivering high-quality samples, advanced analytics, and integrated laboratory services that move research forward


Discovery Life Sciences (Discovery) accelerates the path from biospecimen to breakthrough — delivering high-quality samples, advanced analytics, and integrated laboratory services that move research forward